The high mortality rates from COVID-19 among black patients and other racial/ethnic minorities put a much-needed spotlight on the “deep-rooted failures” of the U.S. healthcare system to improve care for cardiovascular disease (CVD), according to a new commentary.

Taking evolocumab to lower LDL cholesterol can lead to significant reductions in a patient’s risk of myocardial infarction (MI), according to new findings published by JAMA Cardiology.

The first known death from COVID-19 in the United States was caused by a ventricular rupture.  

Hospitalized COVID-19 patients experience a high rate of thromboembolic complications, according to new findings published in Thrombosis Research.

Cardiologs has announced the beginning of a new clinical trial that will involve monitoring the cardiac health of COVID-19 patients being treated with hydroxychloroquine and azithromycin.

Work-related stress is associated with an increased risk of peripheral artery disease (PAD), according to a new study published in the Journal of the American Heart Association.

Experienced dyad and triad partners share tips for setting the stage for success and putting the brakes on mistakes.

Multidisciplinary teams are leveraging advanced technologies to explore the link between cardiovascular disease and dementia with an eye toward improving the diagnosis and treatment of both.